Based on interview and record review, the facility failed to ensure each resident in a nursing facility is screened for a mental disorder (MD) or intellectual disability (ID) prior to admission and that individuals identified with MD or ID are evaluated and receive care and services in the most integrated setting appropriate to their needs to four of four sampled residents (Resident12, 17, 48, and 66) reviewed for Preadmission Screening and Resident Review (PASARR, a federal assessment requirement to help ensure that individuals who have a mental disorder or intellectual disabilities are placed in facilities that can provide the appropriate care) by failing to 1. …
F645 citations in California
PASARR screening · Resident Assessment and Care Planning Deficiencies
PASARR screening for Mental disorders or Intellectual Disabilities
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
Against expectation — 2025
California cites F645 more often than its own record predicts
1.14 times the share F645 takes of citations nationally.
Of every deficiency written in California in 2025, this is the portion that was F645.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What California surveyors wrote
F645 findings written in California, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
Based on interview, medical record review, and facility P&P review, the facility failed to ensure the PASRR level 1 contained accurate information for one of two final sampled residents (Resident 3) reviewed for PASRR. * Resident 3 had the diagnosis of major depressive disorder (mood disorder characterized by persistent sadness, hopelessness, and loss of interest in activities lasting at least two weeks) and was prescribed quetiapine (antipsychotic medication). However, the PASRR level 1 showed Resident 3 had no diagnosed mental illness and was not prescribed the psychotropic medication. …
The short window
Recent years
| Year | Share of California citations | vs expected |
|---|---|---|
| 2023 | 0.46% | 0.79× |
| 2024 | 0.68% | 1.06× |
| 2025 | 0.69% | 1.14× |
Shares of citations, not counts: earlier years hold fewer inspections.
What else California surveyors cite →
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction